Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015433
Filing Date
2024-11-13
Accepted
2024-11-13 07:30:34
Documents
83
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lqda-20240930x10q.htm   iXBRL 10-Q 1955259
2 EX-10.4 lqda-20240930xex10d4.htm EX-10.4 584091
3 EX-10.5 lqda-20240930xex10d5.htm EX-10.5 72534
4 EX-31.1 lqda-20240930xex31d1.htm EX-31.1 15304
5 EX-31.2 lqda-20240930xex31d2.htm EX-31.2 15333
6 EX-32.1 lqda-20240930xex32d1.htm EX-32.1 7569
7 EX-32.2 lqda-20240930xex32d2.htm EX-32.2 7576
8 GRAPHIC lqda-20240930x10q002.jpg GRAPHIC 631
9 GRAPHIC lqda-20240930xex10d5001.jpg GRAPHIC 939
  Complete submission text file 0001558370-24-015433.txt   8943662

Data Files

Seq Description Document Type Size
10 EX-101.SCH lqda-20240930.xsd EX-101.SCH 69863
11 EX-101.CAL lqda-20240930_cal.xml EX-101.CAL 49206
12 EX-101.DEF lqda-20240930_def.xml EX-101.DEF 194269
13 EX-101.LAB lqda-20240930_lab.xml EX-101.LAB 546879
14 EX-101.PRE lqda-20240930_pre.xml EX-101.PRE 369395
86 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20240930x10q_htm.xml XML 1377391
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 241451183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)